KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $30.7 million.

  • Fulgent Genetics' Shares Outstanding (Weighted Average) rose 109.48% to $30.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.7 million, marking a year-over-year increase of 109.48%. This contributed to the annual value of $30.1 million for FY2022, which is 234.29% up from last year.
  • Latest data reveals that Fulgent Genetics reported Shares Outstanding (Weighted Average) of $30.7 million as of Q3 2025, which was up 109.48% from $30.7 million recorded in Q2 2025.
  • Fulgent Genetics' Shares Outstanding (Weighted Average)'s 5-year high stood at $30.8 million during Q1 2025, with a 5-year trough of $28.8 million in Q1 2021.
  • Over the past 5 years, Fulgent Genetics' median Shares Outstanding (Weighted Average) value was $30.1 million (recorded in 2022), while the average stood at $30.0 million.
  • As far as peak fluctuations go, Fulgent Genetics' Shares Outstanding (Weighted Average) surged by 3449.82% in 2021, and later crashed by 230.87% in 2023.
  • Over the past 5 years, Fulgent Genetics' Shares Outstanding (Weighted Average) (Quarter) stood at $29.4 million in 2021, then increased by 2.34% to $30.1 million in 2022, then dropped by 0.28% to $30.0 million in 2023, then increased by 1.34% to $30.4 million in 2024, then rose by 1.09% to $30.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $30.7 million for Q3 2025, versus $30.7 million for Q2 2025 and $30.8 million for Q1 2025.